CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,335.00
-5.00 (-0.21%)
At close: Sep 11, 2026

CU Medical Systems Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
62,39948,22340,62941,80346,95735,402
Other Revenue
----0-0-
62,39948,22340,62941,80346,95735,402
Revenue Growth
52.97%18.69%-2.81%-10.98%32.64%25.01%
Cost of Revenue
27,78519,78519,16921,47922,30916,980
Gross Profit
34,61428,43821,46020,32424,64818,422
Selling, General & Admin
14,07812,04010,0299,1869,3128,072
Research & Development
2,4652,4652,1862,9122,6231,845
Amortization of Goodwill & Intangibles
438.05438.05422414.33408.03892.08
Other Operating Expenses
258.92258.92182.92108.32212.62100.13
Operating Expenses
19,40317,36514,10615,26413,36616,047
Operating Income
15,21111,0737,3545,06011,2822,376
Interest Expense
-1,446-1,446-1,147-325.57-454.24-1,136
Interest & Investment Income
523.13523.13260.3189.7198.72162.01
Earnings From Equity Investments
---105.46-52.92
Currency Exchange Gain (Loss)
-525.16-525.16685.08-107.07311.12363.39
Other Non Operating Income (Expenses)
4,547465.6-720.52137.38-347.03-4,082
EBT Excluding Unusual Items
18,31010,0906,4334,96010,891-2,264
Gain (Loss) on Sale of Investments
-8,585-8,585-9,214-9,637-1,024-8,046
Gain (Loss) on Sale of Assets
3.53.5-42.814.42861.77-63.41
Asset Writedown
---1,004-2,781-370.57-5,267
Other Unusual Items
--1,353-87.97499.72
Pretax Income
9,7291,509-2,474-7,44310,446-15,140
Income Tax Expense
498.05689.77666.52692.81934.62-999.21
Earnings From Continuing Operations
9,231819.2-3,141-8,1369,511-14,141
Net Income to Company
9,231819.2-3,141-8,1369,511-14,141
Minority Interest in Earnings
481.27--63.65-67.68-85.88160.15
Net Income
9,712819.2-3,204-8,2049,425-13,981
Net Income to Common
9,712819.2-3,204-8,2049,425-13,981
Net Income Growth
------
Shares Outstanding (Basic)
1212101097
Shares Outstanding (Diluted)
1312101097
Shares Change
9.36%18.19%7.11%5.90%33.07%52.90%
EPS (Basic)
809.8667.68-312.88-857.951043.92-2060.53
EPS (Diluted)
774.3767.68-315.00-860.001043.92-2060.53
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
13,7808,629-5,9841,893-8,465-4,696
Free Cash Flow Per Share
1095.52712.86-584.31197.93-937.51-692.09
Gross Margin
55.47%58.97%52.82%48.62%52.49%52.04%
Operating Margin
24.38%22.96%18.10%12.11%24.03%6.71%
Profit Margin
15.56%1.70%-7.89%-19.63%20.07%-39.49%
Free Cash Flow Margin
22.08%17.89%-14.73%4.53%-18.03%-13.26%
EBITDA
18,73214,36610,0136,99512,9334,320
EBITDA Margin
30.02%29.79%24.64%16.73%27.54%12.20%
D&A For EBITDA
3,5213,2932,6581,9351,6511,945
EBIT
15,21111,0737,3545,06011,2822,376
EBIT Margin
24.38%22.96%18.10%12.11%24.03%6.71%
Effective Tax Rate
5.12%45.71%--8.95%-
Advertising Expenses
-1,173868.01817.01995.38194.38